A new study has revealed that a NMDA receptor antagonist called 93-31 can reduce the volume of damaged brain tissue by more than half in a mouse model of ischemic stroke. Researchers also found that administering 93-31 to the mice does not seem to lead to the psychoactive side effects seen with other NMDA receptor antagonists. In the 1990s, researchers identified a class of drugs, NMDA receptor antagonists, that showed promise in the area of stroke. NMDA receptors ...
You have just read an article categorized health
titled Study Reveals a NMDA Receptor Antagonist That Reduces Brain Damage by More Than Half in Stroke.
Written by:
editor - Monday, March 2, 2015
There are currently no comments for "Study Reveals a NMDA Receptor Antagonist That Reduces Brain Damage by More Than Half in Stroke"
Post a Comment